---
schema_version: "secwatch.filing_event.v1"
accession: "0001413329-25-000011"
form_type: "8-K"
ticker: "PM"
cik: "0001413329"
company_name: "Philip Morris International Inc."
filed_at: "2025-02-06T23:59:59+00:00"
generated_at: "2026-05-27T01:34:25.881765+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# PMI: FY2024 adj. diluted EPS $6.57 (+9.3%); reported EPS $4.52; smoke-free 40% of net revenue

## Summary
- FY2024 reported diluted EPS $4.52; adjusted diluted EPS $6.57 (+9.3%, +15.6% currency-neutral); $6.01 before Canada impairment $1.49.
- Smoke-free business: FY net revenues +14.2% (+16.7% organic); gross profit +18.7% (+22.7% organic); now 40% of total net revenues, 42% of gross profit.
- IQOS HTU adjusted IMS volume +12.6% full year; Q4 +~13%; ILUMA i driven double-digit growth in Japan; HTU >50% nicotine offtake share in 10 major cities.
- FDA authorized all ZYN pouches in U.S.; PMI hopes other pending FDA applications accelerated.

## SEC filing metadata
- accession: 0001413329-25-000011
- form_type: 8-K
- ticker: PM
- cik: 0001413329
- company_name: Philip Morris International Inc.
- filed_at: 2025-02-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1413329/000141332925000011/0001413329-25-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1413329/000141332925000011/pm-20250206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001413329-25-000011
- JSON: https://secwatch.observer/filing/0001413329-25-000011.json
- Plain text: https://secwatch.observer/filing/0001413329-25-000011.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.